Antipsychotics and Risk of Hyperglycemic Emergencies
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the use of atypical antipsychotic
medication increases the risk of hospitalization for a hyperglycemic emergency.
The investigators will carry out separate population-based cohort studies using
administrative health databases in eight jurisdictions in Canada and the UK. Cohort entry
will be defined by the initiation of a new antipsychotic medication. Follow-up will continue
until hospitalization for a hyperglycemic emergency or the end of 365 days. The results from
the separate sites will be combined to provide an overall assessment of the risk of
hyperglycemic emergencies among new users of various antipsychotic drugs.
Details
Lead Sponsor:
Canadian Network for Observational Drug Effect Studies, CNODES
Collaborators:
Canadian Institutes of Health Research (CIHR) Drug Safety and Effectiveness Network, Canada